LYMEU:SW:SW-Lyxor MSCI Europe (DR) UCITS ETF Acc EUR (CHF)

ETF | Others |

Last Closing

USD 181.98

Change

0.00 (0.00)%

Market Cap

USD 0.71B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

+0.09 (+0.68%)

USD 1,244,681.59B
SPISI:SW UBS ETF (CH) - SPI® ESG (CHF)..

N/A

USD 590,186.66B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.16 (+0.74%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

+36.00 (+0.36%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

-16.00 (-0.25%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

-14.00 (-0.69%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

-9.50 (-0.37%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

+0.74 (+0.97%)

USD 131,872.43B

ETFs Containing LYMEU:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.92% 81% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.92% 81% B- 78% C+
Trailing 12 Months  
Capital Gain 2.22% 42% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.22% 38% F 40% F
Trailing 5 Years  
Capital Gain 52.69% 63% D 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.69% 61% D- 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 8.19% 68% D+ 69% C-
Dividend Return 8.19% 68% D+ 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.36% 26% F 34% F
Risk Adjusted Return 61.31% 41% F 47% F
Market Capitalization 0.71B 63% D 59% D-

Annual Financials (CHF)

Quarterly Financials (CHF)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.